Log In
BCIQ
Print this Print this
 

Co-ArgI-PEG (AEB1102)

  Manage Alerts
Collapse Summary General Information
Company Aeglea BioTherapeutics Inc.
DescriptionPegylated human recombinant arginase 1 (ARG1)
Molecular Target Arginase 1 (ARG1)
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today